[HTML][HTML] ARe we there yet? Understanding androgen receptor signaling in breast cancer

AR Michmerhuizen, DE Spratt, LJ Pierce… - NPJ breast cancer, 2020 - nature.com
The role of androgen receptor (AR) activation and expression is well understood in prostate
cancer. In breast cancer, expression and activation of AR is increasingly recognized for its …

Low‐dose rate brachytherapy for men with localized prostate cancer

F Peinemann, U Grouven, LG Hemkens… - Cochrane Database …, 2011 - cochranelibrary.com
Background Localized prostate cancer is a slow growing tumor for many years for the
majority of affected men. Low‐dose rate brachytherapy (LDR‐BT) is short‐distance …

Effects of in Utero Exposure to DI(n-Butyl) Phthalate on Development of Male Reproductive Tracts in Sprague-Dawley Rats

TS Kim, KK Jung, SS Kim, IH Kang… - Journal of Toxicology …, 2010 - Taylor & Francis
The purpose of this study was to determine the effects of di (n-butyl) phthalate (DBP)
administration on male reproductive organ development in F1 Sprague-Dawley rats …

[HTML][HTML] A combined in vitro-in silico method for assessing the androgenic activities of bisphenol A and its analogues

CG Park, KM Adnan, H Cho, CS Ryu, J Yoon, YJ Kim - Toxicology in Vitro, 2024 - Elsevier
Interactions between endocrine-disruptor chemicals (EDCs) and androgen receptor (AR)
have adverse effects on the endocrine system, leading to human reproductive dysfunction …

Rising PSA in nonmetastatic prostate cancer.

JW Moul, LL Banez, SJ Freedland - Oncology (Williston Park, NY), 2007 - europepmc.org
Rising prostate-specific antigen (PSA) in nonmetastatic prostate cancer occurs in two main
clinical settings:(1) rising PSA to signal failed initial local therapy and (2) rising PSA in the …

Leuprorelin depot injection: patient considerations in the management of prostatic cancer

Z Abouelfadel, ED Crawford - Therapeutics and Clinical Risk …, 2008 - Taylor & Francis
Hormone therapy is well established for treating patients with prostate cancer and remains
the mainstay of the treatment of metastatic and locally advanced disease, this article reviews …

Combined low‐dose flutamide plus finasteride vs low‐dose flutamide monotherapy for recurrent prostate cancer: a comparative analysis of two phase II trials with a …

LL Bañez, GW Blake, DG McLeod… - BJU …, 2009 - Wiley Online Library
OBJECTIVE To compare the efficacy and tolerability of peripheral androgen blockade using
combined low‐dose flutamide plus finasteride vs low‐dose flutamide monotherapy for …

The male sexual revolution: independence from testosterone

JH Park, EF Rissman - Annual Review of Sex Research, 2007 - Taylor & Francis
Much of our knowledge concerning the physiology of male sexual behavior has been based
on classic work on animal models in which gonadal steroids are intimately tied to the …

前列腺癌患者睾丸变化初步研究

兰厚金, 陈赟, 徐林锋, 章宜芬 - 实用老年医学, 2008 - cqvip.com
目的通过对前列腺癌患者双侧睾丸切除标本的回顾性研究, 找出药物去势治疗前后睾丸变化的
规律. 方法将127 例行双侧睾丸切除术的前列腺癌患者, 按照睾丸切除前治疗情况分为5 组, A …

Conception de nouveaux agents iodés pour l'imagerie TEMP des récepteurs 5-HT4

V Babin - 2018 - theses.hal.science
La maladie d'Alzheimer est une maladie neurodégénérative touchant près d'un million de
personnes en France et dont les perspectives actuelles laissent suggérer une forte …